Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Vifor Pharma
Vifor Pharma
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Vifor Pharma to propose Åsa Riisberg for board of directors
Riisberg holds a MSc in Financial Economics and Business Administration from Stockholm School of Economics
Ingredients
Vifor Pharma enters Chinese joint venture with Fresenius Kabi
Joint venture will bring IV Iron to China to replace the wasteful blood transfusions that are the current prevailing treatment for iron deficiency anaemia
Finance
Vifor Pharma enters commercial diabetes collaboration in the US
The Swiss pharma company will work with US-based Janssen to jointly commercialise INVOKANA (canagliflozin) in the US to address complications of type 2 diabetes
Drug Delivery
PIVOTAL trial confirms long-term safety and efficacy of IV iron dosing
The long-term safety and efficacy of intravenous iron dosing has been confirmed allowing higher Ferritin concentration and transferrin saturation in patients undergoing haemodialysis
Recruitment
Vifor pharma announces management changes
Media
Vifor Pharma proposes Jacques Theurillat as board member
Pharmaceutical
Kissei to market Avacopan in Japan for Vifor Pharma
Vifor Fresenius Medical Care Renal Pharma has granted Japanese pharmaceutical company, Kissei, exclusive rights to develop and commercialise Avacopan in Japan
Subscribe now